Mrs Lina Kayal, LCSW in Lena, LA - Social Worker

Mrs Lina Kayal, LCSW is a Social Worker - Clinical based in Lena, Louisiana. Mrs Lina Kayal is licensed to practice in Louisiana (license number 7513) and her current practice location is 8830 Highway 1 N, Lena, Louisiana. She can be reached at her office (for appointments etc.) via phone at (318) 793-5336.

NPI number for Mrs Lina Kayal is 1952674871 and her current mailing address is 5277 Rue Notre Dame, Alexandria, Louisiana. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1952674871.

Contact Information

	Mrs Lina Kayal, LCSW
	8830 Highway 1 N, Lena, LA 71447-9681
	(318) 793-5336
	Not Available

Healthcare Provider's Profile

Full Name	Mrs Lina Kayal
Gender	Female
Speciality	Social Worker - Clinical
Location	8830 Highway 1 N, Lena, Louisiana
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1952674871
Provider Enumeration Date: 02/23/2012
Last Update Date: 08/02/2022

Medical Identifiers

Medical identifiers for Mrs Lina Kayal such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1952674871	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
1041C0700X	Social Worker - Clinical	7513 (Louisiana)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Mrs Lina Kayal is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Mrs Lina Kayal, LCSW 5277 Rue Notre Dame, Alexandria, LA 71303-2200 Ph: (318) 473-0909	Mrs Lina Kayal, LCSW 8830 Highway 1 N, Lena, LA 71447-9681 Ph: (318) 793-5336

News Archive

New analysis reveals the economic burden of polycystic ovary syndrome in the U.S.

The most common hormone disorder affecting women of reproductive age-;polycystic ovary syndrome (PCOS)-;cost an estimated $8 billion to diagnose and treat nationwide in 2020, according to a new economic analysis published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism.

Dana-Farber Cancer Institute receives 2009 MMRC Center of the Year Award

The Multiple Myeloma Research Consortium (MMRC) today announced that it has awarded the Dana-Farber Cancer Institute, and its clinical researchers, Kenneth Anderson, MD, and Paul Richardson, MD, with the 2009 MMRC Center of the Year Award.

Study finds connection between obesity and sociodemographic, economic characteristics

Nearly 70 percent of the U.S. adult population meets the definition of overweight or obese, but a new study by University of Arkansas researchers shows the problem isn't randomly distributed across the country. Instead, obesity is concentrated in areas with social and demographic factors that create what researchers term an "ecology of disadvantage."

Atrium Medical presents interim results from its COBEST clinical study at the 2009 VIVA meeting

Atrium Medical Corporation is proud to announce the release of the interim results from the COBEST clinical study. This study is to evaluate the use of bare metal stents vs. balloon expandable covered stents for the treatment of aorto-iliac occlusive disease. Prof. Patrice Mwipatayi of Royal Perth Hospital, Australia, presented interim data on the Covered versus Balloon Expandable Stent Trial known as COBEST at the 2009 VIVA (Vascular InterVentional Advances) meeting in Las Vegas.

VisEn Medical expands FMT imaging platform

VisEn Medical Inc., a leader in fluorescence imaging solutions from research through medicine, announced today that it has expanded its leading FMT imaging platform with an FMT™ Multi-Species Imaging Module, to extend FMT imaging and related applications into larger preclinical animal models. VisEn also announced that it will be presenting new study results from its recently-launched Cat B 750 FAST™ and Annexin-Vivo™ fluorescence imaging agents at the AACR 101st Annual Meeting.

Mrs Lina Kayal, LCSW - Clinical Social Worker in Lena, LA